YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Antiherpetic Activities of Natural Naringenin Alone and in Combinations with Acyclovir and Vidarabine

천연 나린게닌의 항허피스바이러스작용과 아시클로버 및 비다라빈과의 병용효과

  • Published : 1999.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

To search for less toxic antiherpetic agents, the inhibitory effects of natural naringenin on the plaque formation of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in Vero cells were examined by the plaque reduction assay in vitro. Naringenin inhibited plaque formations of HSV-l and HSV-2 in a dose dependent manner. It also exhibited more potent antiherpetic activity on HSV-l with selectivity index (SI) of 19.1 than on HSV-2 with SI of 5.7 The combined antiherpetic effects of naringenin with nucleoside antiherpetic agents, acyclovir and vidarabine, were examined on the multiplication of these two strains of herpesviruses in Vero cells by the combination assay. The results of combination assay were evaluated by the combination index (CI) that was calculated by the multiple drug effect analysis. The combinations of naringenin with acyclovir on HSV-l and HSV-2 showed more potent synergism with CI values of 0.28∼0.81 for 50%, 70%, 90% effective levels than those with vidarabine with CI values of 0.86-3.28.

Keywords

References

  1. The bloomsbury series in clinical science Herpes simplex virus Mindel. A.
  2. Il Farmaco v.48 no.7 An tiherpes virusf agents : A review Lapucci, A.;Macchina, M.;Parkin, A.
  3. J. Infec. Dis. v.165 Herpes simplex virus infection as a risk factord for human immunodefiency virus in fection in heterosexuals Hook, E. W. Ⅲ. Cannon, R. O.;Nahmias, A. J.
  4. Antimicrob. Agents Chemother v.36 Pesistance to herpesviruses to antiviral drugs Chatis, P. A.;Crumpacker, C. S.
  5. N. Engl. Med. v.317 The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex Richman, D. D.;Fischi, M. A.;Grieco, M. H.
  6. J. Antimicrob. Chemother. v.18 no.Sup. B General aspects of virus drug resistance with special referenced to herpes simplex virus Coen, D. M.;
  7. Combined therapeutic modalities for viruses-rationale and clinical potential Molecular mechanisms of chemotherapeutic synergism, potentiation and antagonism Schinazi, R. F.;T-C. Chou(ed.);D. C. Rideout(ed.)
  8. Antimicrob. Agents Chemother. v.22 no.3 Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice Schinazi, R. F.;Peters, J.;Williams, C. C.;Chance, D.;Nahmias, A. J.
  9. Acta virol. v.28 Combined antiviral effects of flavonoids and 5-ethyl-2'-deoxyuridine on the multiplicaiton of herpesviruses Musci. I.
  10. Antiviral Res. v.7 Synergistic action of quercetin and murine alpha/beta interferon in the treatment of Mengo virus infection in mice Veckenstedt, A.'Guttner, J.;Beladi, I.
  11. J. Ame.Pharm. Asso. v.44 no.7 Some biological effects of the flavonoids Willaman, J. J.
  12. Plant Mol Biol. v.26 no.2 Protection from UV-B-induced DNA damage by flavonoids Kootstra A.
  13. Biochem. Pharmacol. v.50 no.9 Naringenin; a weakly estrogenic bioflavonoid that exhibits antiestrogenic activitiy Ruh M. F.;Zacharewski, T.;Connor K;Howell J.;Chen I.;Safe S.
  14. Stanford med. Bull. v.7 Antiviral Chemetherapy, Ⅲ. Flavones and related compounds Cutting, W. C.;Dreisbach, R. H.;Neff, B. J.
  15. Annals New York Academy Sciences v.284 Activity of some flavonoids against viruses Beladi, I.;Pusztai, R.;Mucsi, I.;Bakay, M.;Gabor, M.
  16. Antiviral Research v.12 Inhibition of reverse transcriptasessdf by flavonoids Gary, S.;Anil, R.;Elliott, M., Jr.
  17. Chemotherapy v.39 Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid Barnard, D. L.;Smee, D. F.;Huffman, J. H.;Meyerson, L. R.;Sidwell, R. W.
  18. Chemotherapy v.39 Mode of Inhibiton of respiratory syncytial virus by a plant flavonoid, SP-303 Barnaed, D. L.;Huffman, J. H.;Meyerson, L. R.;Sidwell, R. W.
  19. Chemotherapy v.40 Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid Sidwell, R,. W.;Huffman, J. H.;Moscon, B. J.;Warren, R. P.
  20. J. Am. Chem. Soc. v.61 George, N. P.;Harry, W.;von Loesecke
  21. Food Research v.5 Wilson, R. H.;D Floyed
  22. Kor, J. Mycol. v.16 Studies on antimicrobial activities and safety of natural naringin in Korea Han, S. S.;You, I. J.
  23. Methods in Enzymology v.78 Virus plaque-reduction assay for Interferon; Microplaque and reular macroplaque reduction assays Langford, M. P.;Weight, D. A.;Sidney Pegstka(eds.)
  24. Cancer Res. v.48 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Scubiero, D. A.;Shoemaker, R. H.;Paull, K. D.;Monks, A.;Tierney, S.;Nofziger, T. H.;Currens, M. J.;Seniff, D.;Boyd, M. R.
  25. Antivral Chem. Chemother. v.3 no.3 Synergistic inhibition of human immunodeficiency virus type Ⅰ in vitro by interferon alpha and coumermycin A1 Tachedjian, G.;Tyssen, D.;Jardine, D.;Lorcarnini, S.;Birch, C.
  26. Adv. Enzyme Regul. v.22 Quantitative analysis of dose-effect relationships: The Combined effects of multiple drugs or enzyme inhibitors Chou, T. C.;Talaly, P.
  27. Experientia v.41 Inhibition of virus multiplication and alteration of cclic AMP level in cell cultures by flavonoids Mucsi, I.;Pragai, B. M.
  28. Antimicrob. Agents Chemother. v.22 Antipicornavirus Flavone Ro 090179 Ishitsuka, H.;Ohsawa, C.;Ohiwa, T.;Umeda,I.;Suhara, Y.
  29. Antiviral Res. v.11 no.5-6 Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus Superti, F.;Seganti, L.;Orsi, N.;Divizia, M.;Gabrieli, R.;Pana, A.;Stein, M. L.